CMS’ Center for Medicare and Medicaid Innovation (CMMI) has announced a new model that aims to lower prescription drug prices in Medicare Part D and introduced several updates to Medicare Advantage (MA) plans.

The Trump administration’s CMS has proposed a number of changes to the 2020 coverage year, including making changes to the individual health insurance exchange and qualified health plan provisions.

The healthcare sector remains a sweet spot for the stock market, ranked the most favored sector on the S&P 500 among Wall Street research firms, Reuters reported.

Rising drug prices have caught the attention of the Congressional Committee on Oversight and Reform, which announced it will open a “sweeping” drug price investigation.

Americans are concerned about higher drug costs impacting their wallets, but hospitals and health systems have also been feeling the pinch, according to a recent study from hospital groups including the American Hospital Association.

Healthcare plans and providers are increasingly addressing social determinants of health that can impact patient outcomes and overall costs. Now, California-based Kaiser Permanente is looking at tackling housing insecurity with a $100 million loan fund for affordable housing.

In 2018, the hot M&A market showed no signs of slowing down, with 90 deals announced during the year, according to a recent report from Kaufman Hall.

Walmart and CVS Health will no longer be in the same network for filling prescription drugs after the two companies couldn’t come to a drug pricing agreement, CVS announced.